Gene Review:
Map2k2 - mitogen activated protein kinase kinase 2
Rattus norvegicus
Synonyms:
Dual specificity mitogen-activated protein kinase kinase 2, ERK activator kinase 2, MAP kinase kinase 2, MAPK/ERK kinase 2, MAPKK 2, ...
- Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis. Ishikawa, S., Egami, H., Kurizaki, T., Akagi, J., Tamori, Y., Yoshida, N., Tan, X., Hayashi, N., Ogawa, M. J. Exp. Clin. Cancer Res. (2003)
- A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function. Catling, A.D., Schaeffer, H.J., Reuter, C.W., Reddy, G.R., Weber, M.J. Mol. Cell. Biol. (1995)
- Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations. Rescan, C., Coutant, A., Talarmin, H., Theret, N., Glaise, D., Guguen-Guillouzo, C., Baffet, G. Mol. Biol. Cell (2001)
- Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. Servant, M.J., Giasson, E., Meloche, S. J. Biol. Chem. (1996)
- The transcription factors CREB and c-Fos play key roles in NCAM-mediated neuritogenesis in PC12-E2 cells. Jessen, U., Novitskaya, V., Pedersen, N., Serup, P., Berezin, V., Bock, E. J. Neurochem. (2001)
- Identification of an amino acid sequence motif in the cytoplasmic domain of the NCAM-140 kDa isoform essential for its neuritogenic activity. Kolkova, K., Pedersen, N., Berezin, V., Bock, E. J. Neurochem. (2000)
- MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Duncia, J.V., Santella, J.B., Higley, C.A., Pitts, W.J., Wityak, J., Frietze, W.E., Rankin, F.W., Sun, J.H., Earl, R.A., Tabaka, A.C., Teleha, C.A., Blom, K.F., Favata, M.F., Manos, E.J., Daulerio, A.J., Stradley, D.A., Horiuchi, K., Copeland, R.A., Scherle, P.A., Trzaskos, J.M., Magolda, R.L., Trainor, G.L., Wexler, R.R., Hobbs, F.W., Olson, R.E. Bioorg. Med. Chem. Lett. (1998)
- Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion. Mizukami, Y., Yoshida, K. Biochem. J. (1997)
- PDGF-BB-mediated activation of p42(MAPK) is independent of PDGF beta-receptor tyrosine phosphorylation. Cartel, N.J., Liu, J., Wang, J., Post, M. Am. J. Physiol. Lung Cell Mol. Physiol. (2001)
- Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini. Duan, R.D., Zheng, C.F., Guan, K.L., Williams, J.A. Am. J. Physiol. (1995)